To Sleep, To Awake (October)

Date of Issue: 10/01/2004 | Volume: 2 | Number: 10

Issue Links: | Editorial Information

While sleeping pills have been around for a long time, the modern age of hypnotics began December 16, 1992, when the FDA approved Ambien (zolpidem). Sonata (zaleplon), a late bloomer, received approval in 1999.

In This Issue

Article

Sleeping Pills: An Update

While sleeping pills have been around for a long time, the modern age of hypnotics began December 16, 1992, when the FDA approved Ambien (zolpidem). Sonata (zaleplon), a late bloomer, received approval in 1999.

Read More
Article

Provigil: It Has the Midas Touch

The FDA may not like it, but Provigil (modafinil) is hot, and getting hotter.

Read More
Article

Common Sleep Disorders: What Not to Miss

While there are plenty of excessively complicated classifications of sleep disorders in this world, TCR, in the midst of a sleep-deprived delirium, has decided that psychiatrists should become most familiar with the following four common problems ...

Read More
Expert Q&A

Dr. John Winkelman On Treating Sleep Disorders

Dr. Winkelman, could you recommend a practical approach for psychiatrists diagnosing sleep disorders?

Read More
Anecdotes from the Field

Beware Benadryl!

In practicing addiction medicine and psychiatry, I have found that the judicious use of Ambien or Sonata has a place in the management of early abstinence, especially since insomnia is an oft-cited cause of relapse. However, the use of Benadryl and Vistaril are problematic in the treatment of insomnia and anxiety in the substance dependent population.

Read More